Yes, I noticed the same. What frustrates me is that a certain poster over there has been saying "oh come on it must not be working or we would hear something" now that they have released a few details a few other posters are accusing CTIX of releasing info too early because it could be misleading. I say those posters should go suck eggs.
In checking on the metastatic implications I ran across a term "null" P53. A previous paper on Kevetrin said it was active on "null" P53. I have not seen the term used on the Kevetrin literature so that's why I want to ask Leo about it because it relates to metastasis.
In checking on the metastatic implications I ran across a term "null" P53. A previous paper on Kevetrin said it was active on "null" P53. I have not seen the term used on the Kevetrin literature so that's why I want to ask Leo about it because it relates to metastasis.